SG10201501606VA - Compounds, compositions, formulations and their uses in the treatment of diseases related to copper retention or hepatic disorders - Google Patents
Compounds, compositions, formulations and their uses in the treatment of diseases related to copper retention or hepatic disordersInfo
- Publication number
- SG10201501606VA SG10201501606VA SG10201501606VA SG10201501606VA SG10201501606VA SG 10201501606V A SG10201501606V A SG 10201501606VA SG 10201501606V A SG10201501606V A SG 10201501606VA SG 10201501606V A SG10201501606V A SG 10201501606VA SG 10201501606V A SG10201501606V A SG 10201501606VA
- Authority
- SG
- Singapore
- Prior art keywords
- formulations
- compositions
- compounds
- treatment
- diseases related
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D339/00—Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms
- C07D339/02—Five-membered rings
- C07D339/04—Five-membered rings having the hetero atoms in positions 1 and 2, e.g. lipoic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/04—Chelating agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
- C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
- C07C323/57—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups
- C07C323/58—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups with amino groups bound to the carbon skeleton
- C07C323/59—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups with amino groups bound to the carbon skeleton with acylated amino groups bound to the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Hospice & Palliative Care (AREA)
- Hematology (AREA)
- Toxicology (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Ophthalmology & Optometry (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US31071910P | 2010-03-05 | 2010-03-05 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG10201501606VA true SG10201501606VA (en) | 2015-04-29 |
Family
ID=44170559
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG2012065629A SG183911A1 (en) | 2010-03-05 | 2011-02-26 | Compounds, compositions, formulations and their uses in the treatment of diseases related to copper retention or hepatic disorders |
| SG10201501606VA SG10201501606VA (en) | 2010-03-05 | 2011-02-26 | Compounds, compositions, formulations and their uses in the treatment of diseases related to copper retention or hepatic disorders |
| SG2012065611A SG183910A1 (en) | 2010-03-05 | 2011-02-26 | Compounds, compositions, formulations and their uses in the treatment of diseases related to copper retention or hepatic disorders |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG2012065629A SG183911A1 (en) | 2010-03-05 | 2011-02-26 | Compounds, compositions, formulations and their uses in the treatment of diseases related to copper retention or hepatic disorders |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG2012065611A SG183910A1 (en) | 2010-03-05 | 2011-02-26 | Compounds, compositions, formulations and their uses in the treatment of diseases related to copper retention or hepatic disorders |
Country Status (10)
| Country | Link |
|---|---|
| US (4) | US20110218237A1 (fr) |
| EP (1) | EP2542547B1 (fr) |
| JP (1) | JP5874128B2 (fr) |
| CN (1) | CN102822162A (fr) |
| AU (1) | AU2011222649B2 (fr) |
| BR (1) | BR112012022163B1 (fr) |
| CA (1) | CA2791457C (fr) |
| IL (1) | IL221686A (fr) |
| SG (3) | SG183911A1 (fr) |
| WO (4) | WO2011107870A2 (fr) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2017060914A2 (fr) * | 2015-09-21 | 2017-04-13 | Krisani Biosciences (P) Ltd. | Pénicillamine et ses dérivés pour leur utilisation dans le traitement de la toxicité du cuivre et de nash |
| CN110938100B (zh) * | 2019-12-20 | 2021-02-09 | 武汉纺织大学 | 一种化合物、制备方法及其应用 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7238340B1 (en) * | 1991-11-27 | 2007-07-03 | Cis Bio International | Monoamine, diamide, thiol-containing metal chelating agents |
| US6376548B1 (en) * | 2000-01-28 | 2002-04-23 | Rohm And Haas Company | Enhanced propertied pesticides |
| US20080260653A1 (en) * | 2004-05-06 | 2008-10-23 | Buttar Rashid A | Transdermal Delivery Systems and Transdermal Chelation Preparations |
| CN101113141B (zh) * | 2006-07-19 | 2011-04-13 | 南京圣和药业有限公司 | 光学活性的N-(α-巯基丙酰基)甘氨酸 |
| TW200820963A (en) * | 2006-07-28 | 2008-05-16 | Xenoport Inc | Acyloxyalkyl carbamate prodrugs of α-amino acids, methods of synthesis and use |
| RU2010107273A (ru) * | 2007-07-27 | 2011-09-10 | Этон Фарма, Инк. (Us) | Применение триентина и пеницилламина в качестве средств противодействия контаминации металлами |
| CN102471248B (zh) * | 2009-08-10 | 2015-01-07 | Bhi有限合伙公司 | 用于递送1,3-丙二磺酸的方法、化合物和组合物 |
-
2011
- 2011-02-14 WO PCT/IB2011/000466 patent/WO2011107870A2/fr active Application Filing
- 2011-02-14 WO PCT/IB2011/000456 patent/WO2011107867A2/fr active Application Filing
- 2011-02-17 WO PCT/IB2011/000528 patent/WO2011107877A2/fr active Application Filing
- 2011-02-21 US US13/031,488 patent/US20110218237A1/en not_active Abandoned
- 2011-02-21 US US13/031,472 patent/US20110218236A1/en not_active Abandoned
- 2011-02-21 US US13/031,420 patent/US20110218235A1/en not_active Abandoned
- 2011-02-26 WO PCT/IB2011/000592 patent/WO2011107881A2/fr active Application Filing
- 2011-02-26 SG SG2012065629A patent/SG183911A1/en unknown
- 2011-02-26 US US13/035,934 patent/US20110218238A1/en not_active Abandoned
- 2011-02-26 SG SG10201501606VA patent/SG10201501606VA/en unknown
- 2011-02-26 CN CN2011800125919A patent/CN102822162A/zh active Pending
- 2011-02-26 AU AU2011222649A patent/AU2011222649B2/en not_active Ceased
- 2011-02-26 EP EP11731488.0A patent/EP2542547B1/fr active Active
- 2011-02-26 CA CA2791457A patent/CA2791457C/fr active Active
- 2011-02-26 BR BR112012022163-9A patent/BR112012022163B1/pt active IP Right Grant
- 2011-02-26 SG SG2012065611A patent/SG183910A1/en unknown
- 2011-02-26 JP JP2012555510A patent/JP5874128B2/ja not_active Expired - Fee Related
-
2012
- 2012-08-29 IL IL221686A patent/IL221686A/en active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| WO2011107867A3 (fr) | 2012-01-12 |
| SG183910A1 (en) | 2012-10-30 |
| WO2011107870A2 (fr) | 2011-09-09 |
| JP2013521270A (ja) | 2013-06-10 |
| CA2791457A1 (fr) | 2011-09-09 |
| WO2011107881A2 (fr) | 2011-09-09 |
| WO2011107877A2 (fr) | 2011-09-09 |
| CN102822162A (zh) | 2012-12-12 |
| US20110218238A1 (en) | 2011-09-08 |
| US20110218235A1 (en) | 2011-09-08 |
| EP2542547A2 (fr) | 2013-01-09 |
| AU2011222649A1 (en) | 2012-08-23 |
| CA2791457C (fr) | 2019-12-03 |
| SG183911A1 (en) | 2012-10-30 |
| JP5874128B2 (ja) | 2016-03-02 |
| WO2011107867A2 (fr) | 2011-09-09 |
| WO2011107870A3 (fr) | 2012-01-05 |
| IL221686A (en) | 2017-07-31 |
| WO2011107881A3 (fr) | 2012-02-23 |
| AU2011222649B2 (en) | 2016-04-21 |
| EP2542547B1 (fr) | 2018-01-24 |
| BR112012022163A2 (pt) | 2018-05-08 |
| BR112012022163B1 (pt) | 2021-06-22 |
| US20110218237A1 (en) | 2011-09-08 |
| WO2011107877A3 (fr) | 2012-01-05 |
| US20110218236A1 (en) | 2011-09-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL257581A (en) | New dihydropyrimidineisoquinolinones and their pharmaceutical preparations for the treatment of inflammatory disorders | |
| EP2552433A4 (fr) | Compositions et procédés pour le traitement de troubles somatosensoriels | |
| IL231536A (en) | Indazole-3-carboxamides, pharmaceuticals containing them and their use in the treatment of diseases | |
| IL239355A0 (en) | Compositions of gamma-hydroxybutyrate and their use in the treatment of disorders | |
| EP2827856A4 (fr) | Composés et compositions pour le traitement d'affections musculaires | |
| HK1198909A1 (en) | Compositions and methods for the treatment of hepatic diseases and disorders | |
| EP2528603A4 (fr) | Compositions pharmaceutiques pour le traitement de la douleur et d'autres indications | |
| PL2768936T3 (pl) | Preparaty, ich zastosowanie jako środków do zmywania naczyń lub do wytwarzania środków do zmywania naczyń i ich wytwarzanie | |
| ZA201200944B (en) | Pharmaceutical compositions for the treatment of cancer and other diseases or disorders | |
| EP2897621A4 (fr) | Composés et compositions pour une utilisation dans la prévention et le traitement de troubles associés à l'inflammation, de la douleur et de la fièvre, de troubles de la peau, du cancer et d'états précancéreux de celui-ci | |
| EP2709642A4 (fr) | Compositions thérapeutiques de préparations déterminées à base de plantes, et leurs utilisations | |
| EP2852570A4 (fr) | Compositions et méthodes pour le traitement d'une maladie inflammatoire de l'intestin | |
| PL2892556T3 (pl) | Kompozycje i sposoby odnoszące się do leczenia chorób | |
| HK1197235A1 (zh) | 二氫吡唑、其藥物組合物及其治療生育障礙的用途 | |
| ZA201408057B (en) | Compositions and methods for the treatment of moderate to severe pain | |
| IL200753A (en) | Pharmaceutical preparation containing ib – meca for the treatment of psoriasis | |
| SG10201501606VA (en) | Compounds, compositions, formulations and their uses in the treatment of diseases related to copper retention or hepatic disorders | |
| IL234616A0 (en) | A herbal preparation for the treatment of metabolic diseases | |
| EP2480099A4 (fr) | Compositions et procédés de prévention et de traitement de maladies métaboliques | |
| HK1214771A1 (zh) | 用於治療皮膚病的製劑 | |
| EP2600716A4 (fr) | Procédés et compositions pour le traitement de troubles métaboliques | |
| IT1400089B1 (it) | Composizione in polvere per la prevenzione e il trattamento delle patologie podali degli animali | |
| IL222642A0 (en) | Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives for the treatment of males | |
| AU2010904906A0 (en) | Methods and compositions for the treatment and prevention of skin disorders |